Fundz

Myomar Molecular secured $1.1M in pre-seed funding to revolutionize muscle health monitoring and eyes US market by 2025.

PRIVATEMar 01, 2024

Amount Raised

$1.1 Million

Round Type

Pre-Seed

BiotechnologyHealth Care

Investors

Firehood Angel Camp

Description

Halifax-based healthtech startup Myomar Molecular recently closed a significant $1.1 million CAD in pre-seed funding, propelling the company towards commercializing a first-of-its-kind muscle health monitoring device. The funding, a strategic mix of equity and grants, will bolster Myomar's operational capabilities and support its ambitious plans to introduce a neuromuscular disease-specific test.

Quick answer

Myomar Molecular raised $1.1 Million in a Pre-Seed round, dated March 1, 2024. Investors: Firehood Angel Camp.

How much did Myomar Molecular raise?
Myomar Molecular raised $1.1 Million in a Pre-Seed round on March 1, 2024.
Who invested in Myomar Molecular?
Firehood Angel Camp is named as investors in this round.
What does Myomar Molecular do?
Myomar Molecular is a healthtech startup based in Halifax, pioneering a simple, accessible way to monitor muscle health with innovative test kits and software applications.
Who are the decision-makers at Myomar Molecular?
Fundz holds 1 contact at Myomar Molecular. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Myomar Molecular that raised within 45 days of this round, from Fundz verified event records.

Who to call at Myomar Molecular, and when

A new round usually means Myomar Molecular is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Myomar Molecular raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Myomar Molecular, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Myomar Molecular. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Myomar Molecular

About

Myomar Molecular is a healthtech startup based in Halifax, pioneering a simple, accessible way to monitor muscle health with innovative test kits and software applications.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Myomar Molecular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Myomar Molecular's next move

See what Strategic adds

Myomar Molecular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.